Prulifloxacin compound preparation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 夏中宁
- Publication Date
- 2006-09-27
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to a prulifloxacin compound preparation for treating bacterial infectious diseases. Background technique
[0002] Prulifloxacin (Prulifloxacin) is a fourth-generation quinolone antibacterial drug developed by Japan New Drug Company. Its chemical name is: 6-fluoro-1-methyl-7-[4-(5-methyl-2- Oxo-1,3-dioxol-4-yl)methyl-1-piperazinyl]-4-oxo-4H-[1,3]thiazetidine[3, 2-a] Quinoline-3-carboxylic acid, molecular formula: C 21 h 20 FN 3 o 6 S, molecular weight: 461.46. Prulifloxacin has excellent pharmacokinetic and pharmacodynamic characteristics, broad antibacterial spectrum, few side effects, and is not easy to develop drug resistance. It has good curative effect in clinical treatment of bacterial infections. However, in recent years, due to the increase of bacterial resistance due to the extensive use of antibiotics, the clinical treatment of bacterial infections has been plagued by problems such as complexity, refractory and repe...